Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.

Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature

March 19, 2013 — Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co ...

Home March 19, 2013
Home
Feature

March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the company ...

Home March 13, 2013
Home
Amplatzer Amulet St. Jude Medical Left Atrial Appendage Occluders
Feature

January 29, 2013 — St. Jude Medical Inc. announced European CE mark approval of its Amplatzer Amulet Left Atrial ...

Home January 29, 2013
Home
News

July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S ...

Home July 06, 2012
Home
News

May 14, 2012 — Boston Scientific announced results from the ASA Plavix (ASAP) study, which studied the Watchman Left ...

Home May 14, 2012
Home
Videos | Left Atrial Appendage (LAA) Occluders

Siemens' AcuNav V 3-D intracardiac echo (ICE) catheter offers detailed, live 3-D images of the interior of the heart ...

Home April 06, 2012
Home
Feature | Dave Fornell

Based on my observations and those of the doctors on the Diagnostic & Interventional Cardiology Editorial Advisory Board ...

Home February 01, 2012
Home
News

January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology ...

Home January 25, 2012
Home
News

January 25, 2012 — Terumo Cardiovascular Systems entered into an exclusive agreement with LAAx Inc. to distribute the ...

Home January 25, 2012
Home
News

November 18, 2011 – Boston Scientific’s Watchman left atrial appendage (LAA) closure device has been implanted in the ...

Home November 18, 2011
Home
Feature

August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro ...

Home August 25, 2011
Home
News

May 23, 2011 -- Boston Scientific Corporation announced results from a clinical study evaluating the use of its Watchman ...

Home May 23, 2011
Home
News

May 18, 2011 - Jasbir Sra, M.D., and Tanvir Bajwa, M.D., are the first in Wisconsin to implant a new device in a patient ...

Home May 18, 2011
Home
News

March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent ...

Home March 07, 2011
Home
News

Boston Scientific has completed its acquisition of Atritech. The completion of the transaction follows the signing of a ...

Home March 04, 2011
Home
Subscribe Now